Yong Xu

No ORCID on file · 5 papers in corpus
observational 2024
Diabetes, metabolic syndrome and obesity : targets and therapy ·doi:10.2147/dmso.s434972

OBJECTIVE: Very few and conflicting data are available regarding the correlation between circulating carbohydrate antigen 19-9 (CA19-9) levels and diabetic kidney disease (DKD) and its components including albuminuria and a low estimated gl…

other 2023
BMC psychiatry ·doi:10.1186/s12888-023-05052-9

BACKGROUND: The exosomal lncRNA-miRNA-mRNA networks in first episode schizophrenia (FOS) have not reported yet. This study examined the lncRNA, miRNA and mRNA expression level in exosome derived from first episode schizophrenia (FOS) patien…

lab-animal 2022
Drug design, development and therapy ·doi:10.2147/dddt.s374061

PURPOSE: Puerarin (PUR) is a major bioactive ingredient extracted from the root of Pueraria lobata (Willd.) Ohwi, which is known as Gegen in traditional Chinese medicine. Conventional PUR ophthalmic dosage forms such as solutions and suspen…

other 2012
Zhonghua wai ke za zhi [Chinese journal of surgery]

OBJECTIVE: To investigate the characteristics of transurethral partial cystectomy with a 2 µm laser in diagnosis and treatment for the bladder submucosal lesions in adults. METHODS: Nine patients with suspected pathological diagnosed bladd…

lab-animal 2010
Molecular cancer ·doi:10.1186/1476-4598-9-140

BACKGROUND: Although the incidence of melanoma in the U.S. is rising faster than any other cancer, the FDA-approved chemotherapies lack efficacy for advanced disease, which results in poor overall survival. Lysophosphatidic acid (LPA), auto…